The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Dietary Supplement Enforcement Trends What is FDA looking for? Eurofins USA NDI warning letters fuel criticism of FDA enforcement approach BPC 157 Rapid Pro 500mcg Pure Prescriptions FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures FDA Moves to Reevaluate Several Peptides American Med Spa Association